Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methods

2Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

In this paper, we present the results of a ligand- and structure-based virtual screen targeting LRRK2, a kinase that has been implicated in Parkinson's disease. For the ligand-based virtual screen, the structures of 12 competitor compounds were used as queries for a variety of 2D and 3D searches. The structure-based virtual screen relied on homology models of LRRK2, as no X-ray structure is currently available in the public domain. From the virtual screening, 662 compounds were purchased, of which 35 showed IC50 values below 10 μM in wild-type and/or mutant LRRK2 (a hit rate of 5.3%). Of these 35 hits, four were deemed to have potential for medicinal chemistry follow-up.

Cite

CITATION STYLE

APA

Gancia, E., De Groot, M., Burton, B., & Clark, D. E. (2017). Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methods. Bioorganic and Medicinal Chemistry Letters, 27(11), 2520–2527. https://doi.org/10.1016/j.bmcl.2017.03.098

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free